Introduction
Polyomavirus JC (JCV) is endemic in the human population with seroconversion rates between 70 and 80 % in childhood. Infection leads to lifelong subclinical persistence in healthy individuals and causes the demyelinating central nervous system (CNS) disease progressive multifocal leukoencephalopathy (PML) by cytolytic destruction of oligodendroglia cells in severely immunocompromised patients (Walker & Padgett, 1983) . Although JCV replicates predominantly in the brain and exhibits stringent cell specificity for CNS cells in vivo and in tissue culture (Walker & Frisque, 1986 ) the virus can also be isolated from kidney tissue and urine from immunosuppressed individuals (Frisque & White, 1992) . In contrast to the CNS, infection in the kidney is attenuated and never leads to disease (Arthur & Shah, 1989) . It is believed that this discrepancy might be reflected in the extraordinary genomic heterogeneity of * Author for correspondence. Fax +49 931 201 39 34.
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JCV variants (Drrries, 1984; Martin et al., 1985; Loeber & Drrries, 1988; Myers et al., 1989; Yogo et al., 1990) .
The structure and function of coding regions appear to be almost identical within JCV variants and other members of the polyomavirus family. The amino acid sequence of early and late proteins is highly conserved, indicating that they are functionally related (Fiers et al., 1978; Frisque et al., 1984; Loeber & Drrries, 1988) . The regulatory product of early genes, large tumour antigen (T Ag), is a multifunctional protein involved in the organization of the viral life cycle (Fanning & Knippers, 1992) . As one of the first steps, T Ag directs DNA replication by interaction with the origin of DNA replication (ori; Borowiec et al., 1991; Lynch & Frisque, 1991; DePamphilis, 1993) . The DNA-binding domain maps within a polypeptide that is almost identical in amino acid sequence in JCV and simian virus 40 (SV40) (Simmons et al., 1990a; Parsons et al., 1990; Tavis & Frisque, 1991) . A functional similarity between the T Ags of SV40 and JCV is suggested not only by sequence similarities, but also by the finding that SV40 TAg interacts productively with the JCV ori in vivo and in vitro (Li & Kelly, 1985; Feigenbaum et al., 1987; Lynch & Frisque, 1991) . Whereas protein similarities between virus species appear to be limited to biologically active 0001-2843 © 1995 SGM regions, variants within a single virus species are almost identical in coding sequence. In contrast, however, significant differences are found within non-coding regions of JCV subtypes isolated from PML brain and persistently infected asymptomatic tissue (D6rries, 1984; Martin et al., 1985; Loeber & D6rries, 1988; Myers et al., 1989; Yogo et al., 1990; Major et al., 1992) .
The control region of JCV subtypes can be subdivided into a conserved segment carrying the putative DNA ori and overlapping, highly rearranged enhancer/promoter sequences (Lynch & Frisque, 1991) . In the SV40 genome the ori region consists of a core element and auxiliary domains. The core has a palindromic region on the early side, a central GC-rich region containing the consensus T Ag-binding site II, and an AT-rich auxiliary segment with overlapping enhancer/promoter elements on the late side (Borowiec et al., 1991 ; Parsons et al., 1990) . The architecture of JCV ori regions appear to be similar but, in contrast to SV40, the JCV core ori has a stringent requirement for auxiliary sequences as the core alone is essentially inactive (Lynch & Frisque, 1990; Sock et al., 1991) . This suggests a significant role for auxiliary sequences in the efficiency of JCV DNA replication. The binding elements for transcription factors on the late side of the ori are highly rearranged, variable in number and contain heterogeneous DNA stretches in JCV subtypes (D6rries, 1984; Martin et al., 1985; Loeber & D6rries, 1988; Yogo et al., 1990) . It has been repeatedly discussed that these differences might not only influence early transcriptional activity, but also the DNA replication efficiency of JCV subtypes (Amirhaeri et al., 1988; Lynch & Frisque, 1990 Sock et al., 1991 Sock et al., , 1993 Tavis & Frisque, 1991) .
However, evaluation of virus control mechanisms on the level of DNA replication are hampered by the stringent cell specificity of JCV. Tissue culture cells provide cellular proteins required for JCV DNA replication only to a limited extent and attenuated virus expression in tissue culture limits the amount of T Ag available. To establish a system for the analysis of essential steps in JCV-specific DNA replication we cloned the JCV early coding genomic region in the high expression, helper-independent adenovirus type 5 (Ad5) hybrid vector system (Berkner, 1992) . Specificity and functional activity of recombinant protein was verified by immunoreaction to a T Ag-specific monoclonal antibody and by specific binding to both JCV DNA sequences spanning the putative core ori in deletion mutants and the rearranged control regions of naturally occurring JCV subtypes.
Methods
Cells and viruses. The Ad5-transformed human embryonic kidney cell line 293 (Graham et al., 1977) was grown in Dulbecco's modified Eagle's MEM (DMEM) supplemented with 10% fetal calf serum (FCS). The SV40-transformed mouse cell line VLM was kindly provided by Dr G. Brandner (Institut ffir medizinische Mikrobiologie und Hygiene der Unversit/it Freiburg, Germany). The VLM line and the JCV-transformed hamster cell line HJC-15 (Walker et al., 1973) were grown in MEM supplemented with 10 % FCS. The Ad5 deletion mutant 309 (Ad5d1309; Jones & Shenk, 1979) was propagated in 293 cells, purified by CsC1 gradient centrifugation and virus titres were determined by a plaque assay (Precious & Russell, 1985) .
Plasmids and construction of recombinant virus. JCV strains GS/B and GS/K were cloned in pBR322 at the BamHI site within the early gene region (Loeber & D6rries, 1988) . To obtain an intact TAg gene, the genome of JCV GS/B was recloned in the phagemid pGEM-3Z (Promega) at the EcoRI site located within the late coding region to give pJCV(GS/B)-GEM. The adenovirus-derived shuttle vector pSKAG and the SV40 TAg shuttle vector pSKAT (Simmons et al., 1990a) were kindly provided by Dr D. Simmons (University of Delaware, Del., USA). Standard recombinant DNA procedures were performed as described by Sambrook et al. (1989) and enzymes were used as recommended by the supplier.
For the construction of the JCV T Ag shuttle vector pSKAG-JCT, the vector pJCV(GS/B)-GEM was cleaved by restriction endonucleases MscI and KpnI followed by treatment with exonuclease III at 21 °C (Erase-a-Base; Promega; Henikoff, 1984) to remove elements at the unprotected 5' end of the MscI-KpnI DNA fragment (at about 60 bp/min). Reaction products were treated with S1 nuclease and the Klenow fragment of DNA polymerase I, religated and transformed in Escherichia coli strain 71 / 18 (Sambrook et al., 1989) . The extent of the deletions was determined by agarose gel electrophoresis and further nucleotide sequencing (Tabor & Richardson, 1987 (Graham & van der Eb, 1973) . Cells were incubated under a layer of 1% agar with DMEM and 1M% FCS at 37 °C for 8 9 days. Virus plaques were isolated by aspiration of agar plates. After addition of 0.5 ml DMEM and two rounds of freezing and thawing, recombinant virus was amplified by two passages in 293 cells. JCV TAg recombinants were identified by T Ag-specific immunofluorescence with the monoclonal antibody PAb 416 (Harlow et al., 1981 ; Stoner et al., 1988) . Recombinant SV40 T Agexpressing hybrid virus Ad5-SV40T Ag (Simmons et al., 1990a) was prepared similarly.
Analysis of recombinant JCV T Ag.
For protein analysis, 2 x 106 confluent 293 cells were infected with Ad5d1309 or Ad5-derived recombinant virus at a multiplicity of 10 p.f.u, per cell. Cells were harvested 20 h post-infection (p.i.) or as described in the text. The presence ofJCV TAg was demonstrated in situ by immunofluorescence. Cells were fixed with acetone for 10 min at -20 °C. T Ag-specific monoclonal antibody PAb 416, PAb 419 or a monoclonal antibody directed against the S protein of murine hepatitis virus (MHV) strain JHM, PAb 873 (kindly provided by Dr H. Wege, Institut fiir Virologie und Immunbiologie, Wiirzburg, Germany), were used as primary antibodies at a concentration of 10 gg/ml. Fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG was used as secondary antibody at a concentration of 14 Ixg/ml.
Western blotting was performed on lysates of 2 x 106 cells in 0.25 ml RIPA buffer (Harlow & Lane, 1988) . After separation of cell lysates by PAGE in a 8% denaturing gel, proteins were transferred to nitrocellulose filters. Non-specific binding was blocked by 10 % BSA. Filters strips (3 mm wide) were incubated successively with monoclonal antibodies at a concentration of 1 gg/ml. Horseradish peroxidase (POD)-conjugated goat anti-mouse IgG was used as secondary antibody at a concentration of 1.1 gg/ml. The substrate was 4-chloro-1-naphthol. Western blotting and immunofluorescence were carried out according to standard protocols (Harlow & Lane, 1988) . Molecular masses of proteins were calculated from regression curves of marker proteins (Sigma).
DNA-binding assav. DNA-binding reactions were performed by a modified T Ag-DNA binding assay (Hinzpeter et al., 1986) . Protein lysate (250 Ixl) was immunoprecipitated with an excess of monoclonal antibody PAb 416 and Protein A-Sepharose (Pharmacia). After suspension in 500 gl binding buffer (10mM-HEPES, 150mM-KC1, 1 mM-DTT, 0.5 mM-MgC12, 1 mM-PMSF pH 7.8) JCV DNA fragments from subtypes or deletion mutants were added at different concentrations and incubated for 30 min at 0 °C. The precipitate was washed three times with 1 ml ice-cold NET buffer (50 mM-Tris-HC1, 150 mMNaC1, 5 mM-EDTA, 0"05 % NP40 pH 7"5) and three times with 1 ml ice-cold 10 mM-NaC1 and 15 mM-Tri~HC1 pH 7.8. Bound DNA was eluted for 30 min at 37 °C with 0.1 M-NHaCI pH 9"5 and lyophilized overnight. Radioactive labelling of DNA fragments was performed using the Klenow fragment with [z2P]dATP (sp. act. 1200 Ci/mmol; Amersham) and free nucleotides were removed on a spun column (Sambrook et al., 1989) . Radioactively labelled DNA fragments were separated by electrophoresis on a 1% agarose gel, the gel was dried and DNA fragments were detected by autoradiography with Du Pont Cronex X-ray films and 'lightning plus' enhancer screens. Densitometric scanning for quantification of autoradiographic signals was performed on an ImageQuant densitometer (Molecular Dynamics) using the software 'area integration'.
Results

Construction of the viral JCV T Ag expression hybrid vector AdSJCVTAg
Analysis of the JCV early protein T Ag required higher amounts of protein than were available in transformed or transfected cell lines. Therefore the early coding region was cloned in a helper-independent Ad5 high level expression vector under the control of the Ad2 MLP (Berkner, 1992 replication-inactive Ad5d1309 subfragment (m.u. 4-100; Simmons et al., 1990a) was cotransfected with KpnIlinearized pSKAG-JCT vector DNA in Ad5-transformed 293 cells. These cells express the early Ad5 E1A and E1B proteins constitutively and therefore allowed a recombinant Ad5-JCVTAg hybrid virus to grow carrying the JCV genome segment under the control of the Ad2 MLP between Ad5 m.u. 1.4-9-1. Analysis of plaque isolates revealed the presence of the JCV early gene segment in seven out of 46 plaques, as detected by T Agspecific immunofluorescence in infected 293 cells (Fig. 2) . The activity was identical among all isolates and expression was stable upon further rounds of plaque purification. Recombinant virus grew routinely to high titres (10 s 109 p.f.u./ml) in 293 cells.
Analysis of recombinant JCV T A g synthesis in 293 cells after infection with the hybrid virus Ad5-JCVTAg
To study the course of infection and recombinant JCV T Ag synthesis, 293 cells were infected with the hybrid virus Ad5-JCVTAg or the adenovirus deletion mutant Ad5d1309 at a multiplicity of I0 p.f.u./cell. Morphological alterations resembling adenovirus-induced CPE were detected at 12 h p.i. with the hybrid virus (Precious & Russell, 1985) . From 20 h p.i., rounded cells were released into the medium and by 28 h p.i. almost all cells were in suspension.
T Ag expression was demonstrated by indirect immunofluorescence with the monoclonal antibody PAb 416, which reacts with both JCV and SV40 TAg (Harlow et al., 1981; Stoner et al., 1988) , and FITC-conjugated goat anti-mouse Ig as a secondary antibody (Fig. 2a-c) . (Fig. 2b) . The amount of JCV TAg increased considerably and by 20 h p.i. almost all cells expressed T Ag (Fig. 2 c) . Thereafter, expression appeared to reach a plateau, although between 24 and 28 h the total number of cells decreased. Comparison with the JCV-transformed cell line HJC (Fig. 2d) and 293 cells transfected with the T Agexpressing plasmid pJCV(GS/B)-GEM (Fig. 2 e) revealed that the expression of recombinant JCV T Ag in Ad5-JCV hybrid virus-infected cells was higher than in the other cells and comparable to the expression of SV40 T A g by the recombinant Ad5-SV40TAg hybrid virus (Fig. 2f) .
Characterization of recombinant J C V T A g expressed in human kidney cells
The molecular mass of recombinant JCV T A g was determined by Western blotting of protein lysates from hybrid virus Ad5-JCVTAg-infected cells at 20 h p.i., followed by immunohistological staining with the T Agspecific monoclonal antibody PAb 416 and PODconjugated goat anti-mouse Ig. Recombinant Ad5-JCVTAg virus expressed JCV-specific protein with a molecular mass of about 85 kDa (Fig. 3, lane 1) . This was not detected either in uninfected 293 cells (Fig. 3 , lane 5) or by analysis of any lysates with PAb 419 specific for SV40 early proteins or MHV-specific PAb 873 (Fig.  3 , lane 2, 4, 6, 8, 10) as primary antibody. The electrophoretic mobility of JCV T A g was similar to that expressed in the JCV-transformed cell line HJC (Fig. 3 , lane 7). SV40 T A g is slightly longer in amino acid sequence than JCV T A g (Frisque et al., 1984; Loeber & D6rries, 1988) and comparison of the proteins demonstrated that the electrophoretic mobility of SV40 T A g was reduced in lysates from hybrid virus Ad5-SV40TAg-infected 293 cells and the transformed cell line VLM (Fig. 3, lane 3, 9 ). This corresponds to earlier findings (Lynch & Frisque, 1991) and the calculated length of the SV40 T Ag gene being 60 bp longer than that of JCV T Ag. Specific bands around 90 kDa in JCV-and SV40-transformed cell lines (Fig. 3, lane 7, 8) , the so called 'super T Ags' (Mandl& Frisque, 1986) were not present in recombinant lysates.
DNA binding of recombinant J C V T A g to J C V DNA ori sequences
The DNA-binding activity of recombinant JCV T Ag was analysed by a modified McKay assay performed under almost physiological salt conditions (McKay, 1981; Hinzpeter et al., 1986) . For T A g binding, JCV DNA [pJCV(GS/B)-GEM] was cleaved by the restriction endonuclease BglIII into four fragments (A-D) of lengths 3.7 to 0.7 kb (Fig. 4a, b ). Fragment C (1.6 kb) contains the non-coding region with the putative DNA ori. DNA fragments were incubated with recombinant JCV T A g after immunoprecipitation with monoclonal antibody PAb 416 from a lysate of Ad5-JCVTAginfected 293 cells. T Ag-binding DNA fragments were eluted from the protein, radioactively labelled and autoradiographically visualized after electrophoretic separation. As shown in Fig. 4(a) , JCV fragment C was heavily labelled, indicating binding to the T Ag-specific consensus binding sites within the non-coding control region (Fig. 4a, lane 2) . In almost all experiments, weak binding of fragment A, B and D was observed. This is believed to be a non-specific reaction of T Ag with any DNA sequence (Simmons et al., 1990a) . No reaction was found after immunoprecipitation of T Ag with a nonspecific antibody (PAb 873; Fig. 4a , lane 3, 5) or with lysates from uninfected 293 cells (Fig. 4a, lane 4, 5) , thus confirming the specificity of the signal. This demonstrates that recombinant JCV T A g has DNA-binding activity and binds predominantly to the fragment containing the control region of the JCV genome. The control region of JCV subtype GS/B was truncated in an attempt to localize T Ag-binding DNA segments further. The putative ori and duplicated promoter/enhancer elements (nucleotides 3315-3773; Loeber & D6rries, 1988) were deleted successively by exonuclease III digestion from the late side of the control region (Fig. 5) . T Ag-binding activity was analysed with BglII-and ScaI-cleaved DNA of deletion mutants JCV(GS)dl20, 19, 18 and 15 (Fig. 6) . The cleavage resulted in four fragments A to D (2"1 kb-0.7 kb) with fragment C containing the truncated control region (1-5-1.3 kb). Mutant JCV(GS)dl20 contains the putative ori and one of the enhancer/promoter elements (TR1 ; nucleotides 3315-3519; Fig. 6, lane 4) . The binding assay with recombinant JCV T Ag revealed a strong binding O. Windl and K. D6rries signal at the position of DNA fragment C (1.55 kb). In mutant JCV(GS)dll9, tandemly repeated transcriptional control elements were deleted (nucleotides 3315-3456) leaving an intact core ori sequence and the TATA box within the AT-rich subdomain (Borowiec et al., 1991; Lynch & Frisque, 1990 . No significant difference in the binding of T Ag to fragment C (1.49 kb) was observed (Fig. 6, lane 3) . The core ori in mutant JCV(GS)dl 18 was truncated (nucleotides 3315-3379). T Ag-binding site I (Lynch & Frisque, 1990 ) was left intact and 77 bp, including putative T Ag-binding site II, were removed. In this case, the TAg binding of fragment C (1'41 kb) was diminished (Fig. 6, lane 2) , pointing to the significance of the segment from nucleotide 3456 to 3379. In the construct JCV(GS)dll5, the core ori sequence was truncated to nucleotide 3315 and contained no putative T Ag-binding domains. In this case, T A g binding of fragment C (1"35 kb) was reduced to nonspecific levels (Fig. 6, lane 1) . These findings were confirmed by densitometric quantification and demonstrate that JCV T A g binding is limited to the ori between nucleotides 3315 and 3456. Binding increased depending on the presence of the putative consensus T Ag-binding domains I and II. This demonstrated JCV T Ag binding to both sites and restricted the contact to a 141 bp DNA segment. The specificity of T Ag binding to ori sequences was further supported by binding analyses of wild-type JCV host-derived subtypes with differentially arranged upstream control elements (GS/B, GS/K; Loeber & D6rries, 1988) . The control region contained duplicated enhancer/promoter elements in the GS/B type and single enhancer/promoter elements flanked by a 58 and 46 bp sequence string in the GS/K type (Fig. 5) . Binding was performed by a reaction with Bg/II-restricted genomic DNA fragments. Fragment C, containing the JCV GS/B and GS/K control regions, varied in length (GS/B, 1.61 kb; GS/K, 1.56 kb). Both variant DNA fragments bound JCV TAg with comparable efficiency (Fig. 7a, lanes 3 and 4) . Double bands of fragment C were observed in almost all experiments to a variable extent and might be caused by degradation in the radioactive labelling reaction (McKay, 1981) . The specificity of the reaction was confirmed by binding of constant amounts of TAg to ascending amounts of DNA (Fig. 7a, lanes 10 to 7) . Quantification by densitometry confirmed increasing TAg binding to fragment C corresponding to the amount of DNA used (Fig. 7b) . No binding was observed after immunoprecipitation of extracts with a non-specific antibody (PAb 873; Fig. 7a , lanes 2 and 5) or with lysates from uninfected 293 cells (Fig. 7a , lanes 1 and 6). These findings confirm the specificity of recombinant T Ag binding to naturally occurring JCV subtypes.
Discussion
The concentration of JCV TAg in transformed cell lines or after transient expression of cloned JCV full-length DNA in 293 cells is very low due to limited expression from the weak early JCV promoter. This makes functional studies impractical (O. Windl & K. D6rries, unpublished observations; Tavis & Frisque, 1991) and it was therefore necessary to construct a high-level expression system for JCV TAg. In contrast to transient expression of T Ag by transfected bacterial vectors (Sock et al., 1993; Kerr et al., 1993 ) the adenovirus hybrid vector has the advantage of overexpressing JCV proteins in human kidney cells, because of its viral origins (Berkner, 1992) . This cell type is permissive for JCV infection and it has been reported that splicing in SV40 and post-translational processing of the hybrid virus Ad5-SV40TAg is identical to that in SV40-infected cells (Solnick, 1981; McVey et al., 1989) . As JCV is highly related to SV40, we expected correct processing, thus simplifying the construction of the hybrid vector. Expression of recombinant JCV T Ag from the Ad5-JCVTAg hybrid virus was considerably higher than that from the homologous promoter in the JCV-transformed cell line HJC or in JCV-transfected 293 cells. Comparison with recombinant SV40 TAg expression in the same system revealed that the protein yield obtained with the Ad5-JCVTAg vector is comparable to that reported earlier for SV40. Estimated amounts ranged up to 4 % of total protein in an herpes simplex virus-Ad5 hybrid vector (Lamarche et al., 1990; Berkner, 1992) thus providing a protein level that facilitates enrichment and purification.
Immunoreactivity and the identical size of the recombinant protein to that in productively infected cells and in transformed cell lines (Haggerty et al., 1989; Major & Traub, 1986; Lynch & Frisque, 1991) corroborates the other evidence indicating that endogenous JCV-specific transcription and splicing signals worked well and that protein expression is not affected by surrounding adenovirus sequences (Berkner, 1992) . Specific binding of T Ag molecules to JCV DNA fragments encompassing the core ori within the genomic control region indicated functional activity. As this property is dependent on the phosphorylation state of T Ag (Prives, 1990) we can assume that post-translational modifications of the protein in 293 cells are similar to those in vivo. In SV40, T Ag-binding activity is localized to an amino acid stretch identical to that in JCV TAg, and it is believed to be a prerequisite for the intrinsic helicase activity of T Ag (Simmons et al., 1990b ). Our analyses demonstrate that the recombinant TAg is naturally spliced, intact in length, has functional activity and is expressed in sufficient amounts to allow studies on JCV DNA replication.
T Ag-dependent DNA replication is influenced in vivo by cell-specific expression of the protein and probably by interaction with cellular factors in a host-and cellspecific manner (DePamphilis, 1993) . In the JCV system, sequences on the late side of JCV ori elements were identified that have a significant effect on the activity of DNA replication (Lynch & Frisque, 1990; Sock et al., 1991 Sock et al., , 1993 . However, the first essential task of T Ag in the polyomavirus life cycle is the initiation of DNA replication by binding to DNA ori sequences (Borowiec et al., 1991; DePamphilis, 1993) . To understand the cascade of regulatory events leading to JCV DNA replication we first determined the borders of the DNA binding region, using the reaction of T Ag to ori sequences of truncated control region elements. Since the presence of cellular components in the binding reactions might change T Ag-ori interactions, binding was performed with immunopurified target-bound T Ag, thus avoiding interference by cellular components (Hinzpeter et al., 1986 ). The data demonstrate that a residual 24 bp on the early side of the control region do not mediate specific TAg binding. This localizes the borders of ori sequences to the early side of the control region at nucleotide position 3315, similar to that described by Lynch & Frisque (1990 and Sock et al. (1991 Sock et al. ( , 1993 . The following 64 nucleotides, encompassing T Ag-binding site I with two consensus pentanucleotides, mediate specific TAg binding. Binding efficiency to site I was clearly reduced in comparison to that observed in a mutant containing the complete putative ori sequences with central dyad symmetry, consensus T Ag-binding site II and the AT rich domain.
In SV40, similar consensus sites and flanking sequences of the inverted region have been described as essential segments (Borowiec et al., 1991 ; DePamphilis, 1993) and our results suggest that JCV TAg binds strongly to the same elements. Earlier reports failed to detect JCV T Ag binding to putative JCV T Ag-binding site II, although experiments confirmed strong TAg binding to site II in the SV40 system under the same experimental conditions (Tavis & Frisque, 1991) . Apart from the presence of cellular proteins in those experiments, lysates of a JCVtransformed cell line were used that contained severalfold lower amounts of JCV TAg than SV40 T Ag in the respective cell line. Provided that affinity of binding site I was higher than that of binding site II, as described in the SV40 system (Stetter et al., 1988; Deb & Deb, 1989) , binding to site I would dominate under suboptimal conditions. The use of DdeI to generate fragments containing sites I and II suggests another explanation. DdeI cleaves between the consensus sequences, placing the binding sites at the extreme ends of the DNA fragments. In our hands, binding experiments with oligonucleotides containing JCV T Ag-binding site II were not convincing and it appears likely that the deletion of early flanking sequences might interfere with JCV TAg binding.
DNA-binding experiments to increasing amounts of DNA fragments containing the complete non-coding region of wild-type JCV subtypes in the cell proteir~-free system confirmed the specificity of recombinant TAg binding to the variant control regions. This finding, however, does not contradict the possibility that TAg binding might be influenced by interference of cellular factors (Lynch & Frisque, 1990 Sock et al., 1991 Sock et al., , 1993 DePamphilis, 1993) .
In summary, the data demonstrate that overexpression of the JCV early gene segment in a eukaryotic cell line produced a recombinant protein of JCV T Ag-specific length and antigenicity that specifically bound to the JCV ori within the genomic control region. This will allow future studies addressing questions about the interaction of TAg with DNA sequences in the course of DNA replication and the influence of different cellular factors from permissive and semi-permissive cells.
